Dronedarone for early atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests the drug dronedarone (a medicine that helps control heart rhythm) in people who were diagnosed with atrial fibrillation (an irregular heartbeat) within the past year. The goal is to see if it can help restore normal rhythm and prevent further episodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 19 years old
- Diagnosed with atrial fibrillation within the last 12 months
- Have a life expectancy of at least 1 year
- Be considered a candidate for antiarrhythmic drugs like dronedarone
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether starting treatment early to control your heart's rhythm can help people with a heart device who have short bursts of a fast heartbeat (called atrial high rate episodes) but haven't yet been diagnosed with atrial fibrillation on a standard EKG or Holter monitor.
This trial is testing whether giving amiodarone (a heart-rhythm medicine) before an electrical cardioversion can help restore normal heart rhythm better in people with persistent atrial fibrillation. The goal is to see if the medicine makes the procedure more likely to succeed and reduces the chance of the irregular rhythm returning.
This trial tests whether a target heart rate (below 80 beats per minute) is better than a more lenient one for people with persistent or permanent atrial fibrillation. It aims to find the best way to control your heart rate and improve your quality of life.
This study tests a new medicine, budiodarone, to help control atrial fibrillation (an irregular heartbeat) in people who haven't been helped by other treatments. It may reduce the time spent in AF and improve symptoms.
This trial tests two different ablation techniques to treat a type of irregular heartbeat that doesn't go away on its own. It aims to find which approach works better and is safer.
This trial tests if adding dapagliflozin (a diabetes drug) helps control heart rhythm in people recently diagnosed with atrial fibrillation. It's for those who haven't tried rhythm control treatments before.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.